References
Adelman G, Rane SG, & Villa KF (2013). The cost burden of multiple sclerosis in the United States: a systematic review of the literature. J Med Econ 16: 639-647.
Ascherio A (2013). Environmental factors in multiple sclerosis. Expert Rev Neurother 13: 3-9.
Baecher-Allan C, Kaskow BJ, & Weiner HL (2018). Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron 97: 742-768.
Bang JS, Oh DH, Choi HM, Sur BJ, Lim SJ, Kim JY, et al. (2009). Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther 11: R49.
Bar-Or A, Pachner A, Menguy-Vacheron F, Kaplan J, & Wiendl H (2014). Teriflunomide and its mechanism of action in multiple sclerosis. Drugs 74: 659-674.
Bastaki M, Aubanel M, Bauter M, Cachet T, Demyttenaere J, Diop MM, et al. (2018). Absence of adverse effects following administration of piperine in the diet of Sprague-Dawley rats for 90 days. Food Chem Toxicol 120: 213-221.
Comabella M, & Khoury SJ (2012). Immunopathogenesis of multiple sclerosis. Clin Immunol 142: 2-8.
Dendrou CA, Fugger L, & Friese MA (2015a). Immunopathology of multiple sclerosis. Nat Rev Immunol 15: 545-558.
Dendrou CA, Fugger L, & Friese MA (2015b). Immunopathology of multiple sclerosis. Nature Reviews Immunology 15: 545-558.
Diao Y, Lu W, Jin H, Zhu J, Han L, Xu M, et al. (2012). Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening. J Med Chem 55: 8341-8349.
Dimitrova P, Skapenko A, Herrmann ML, Schleyerbach R, Kalden JR, & Schulze-Koops H (2002). Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation. J Immunol 169: 3392-3399.
Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, & Mills KH (2010). T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162: 1-11.
Friese MA, & Fugger L (2005). Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 128: 1747-1763.
Garnock-Jones KP (2013). Teriflunomide: a review of its use in relapsing multiple sclerosis. CNS Drugs 27: 1103-1123.
Goodnow CC (2007). Multistep pathogenesis of autoimmune disease. Cell 130: 25-35.
Gorgani L, Mohammadi M, Najafpour GD, & Nikzad M (2017). Piperine-The Bioactive Compound of Black Pepper: From Isolation to Medicinal Formulations. Compr Rev Food Sci F 16: 124-140.
Goverman J (2009). Autoimmune T cell responses in the central nervous system. Nat Rev Rheumatol 9: 393.
Holland NJ, Schneider DM, Rapp R, & Kalb RC (2011). Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community. Int J MS Care 13: 65-74.
Jelcic I, Al NF, Wang J, Lentsch V, Planas R, Jelcic I, et al.(2018). Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis. Cell 175 (1): 85-100.e123.
Jennum P, Wanscher B, Frederiksen J, & Kjellberg J (2012). The socioeconomic consequences of multiple sclerosis: a controlled national study. Eur Neuropsychopharmacol 22: 36-43.
Lassmann H, & Bradl M (2017). Multiple sclerosis: experimental models and reality. Acta Neuropathol 133: 223-244.
Liu H, Luo R, Chen X, Liu J, Bi Y, Zheng L, et al. (2013). Tissue distribution profiles of three antiparkinsonian alkaloids from Piper longum L. in rats determined by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 928: 78-82.
Liu S, Neidhardt EA, Grossman TH, Ocain T, & Clardy J (2000a). Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure 8: 25-33.
Liu SP, Neidhardt EA, Grossman TH, Ocain T, & Clardy J (2000b). Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure 8: 25-33.
Lo MC, Aulabaugh A, Jin GX, Cowling R, Bard J, Malamas M, et al.(2004). Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal Biochem 332: 153-159.
Löffler M, Fairbanks LD, Zameitat E, Marinaki AM, & Simmonds HA (2005). Pyrimidine pathways in health and disease. Trends Mol Med 11:430-437.
Löffler M, Jöckel J, & Schuster G (1997). Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides. Mol Cell Biochem 174: 125-129.
Lu WQ, Yao X, Ouyang P, Dong NN, Wu D, Jiang XW, et al. (2017). Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis. J Med Chem 60: 1817-1828.
Manayi A, Nabavi SM, Setzer WN, & Jafari S (2017). Piperine as a potential anti-cancer agent: a Review on Preclinical studies. Curr Med Chem 25 (37): 4918-4928.
Mardiguian S, Serres S, Ladds E, Campbell SJ, Wilainam P, McFadyen C, et al. (2013). Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice. Am J Pathol 182: 2071-2081.
McLean JE, Neidhardt EA, Grossman TH, & Hedstrom L (2001). Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase. Biochemistry 40: 2194-2200.
McNamara FN, Randall A, & Gunthorpe MJ (2005). Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br J Pharmacol 144: 781-790.
Micsonai A, Wien F, Kernya L, Lee YH, Goto Y, Refregiers M, et al. (2015). Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy. Proc Natl Acad Sci U S A 112: E3095-3103.
Munier-Lehmann H, Vidalain PO, Tangy F, & Janin YL (2013). On dihydroorotate dehydrogenases and their inhibitors and uses. J Med Chem 56: 3148-3167.
Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, et al. (2015). Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature 522: 216.
Quemeneur L, Gerland LM, Flacher M, Ffrench M, Revillard JP, & Genestier L (2003). Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides. J Immunol 170: 4986-4995.
Quijia CR, & Chorilli M (2020). Characteristics, Biological Properties and Analytical Methods of Piperine: A Review. Crit Rev Anal Chem 50: 62-77.
Reich DS, Lucchinetti CF, & Calabresi PA (2018). Multiple Sclerosis. N Engl J Med 378: 169-180.
Ridderstad Wollberg A, Ericsson-Dahlstrand A, Jureus A, Ekerot P, Simon S, Nilsson M, et al. (2014). Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis. Proc Natl Acad Sci U S A 111:5409-5414.
Ruckemann K, Fairbanks LD, Carrey EA, Hawrylowicz CM, Richards DF, Kirschbaum B, et al. (1998). Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 273: 21682-21691.
Schmitz K, de Bruin N, Bishay P, Mannich J, Haussler A, Altmann C, et al. (2014). R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice. EMBO Mol Med 6: 1398-1422.
Sykes DB, Kfoury YS, Mercier FE, Wawer MJ, Law JM, Haynes MK, et al. (2016). Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia. Cell 167:171-186.e115.
T Hart BA, & Massacesi L (2009). Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus). J Neuropathol Exp Neurol 68: 341-355.
Wang C, Wu C, Popescu DC, Zhu J, Macklin WB, Miller RH, et al.(2011). Longitudinal near-infrared imaging of myelination. J Neurosci 31: 2382.
Wanke F, Moos S, Croxford AL, Heinen AP, Graf S, Kalt B, et al.(2017). EBI2 Is Highly Expressed in Multiple Sclerosis Lesions and Promotes Early CNS Migration of Encephalitogenic CD4 T Cells. Cell Rep 18: 1270-1284.
Wu D, Wang W, Chen W, Lian F, Lang L, Huang Y, et al. (2018). Pharmacologic inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells. Haematologica.
Xu X, Xu X, Liu P, Zhu ZY, Chen J, Fu HA, et al. (2015). Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor alpha (FXRalpha) in Stabilizing the Homodimerization of the Receptor. J Biol Chem 290: 19888-19899.
Yin S, Kabashima T, Zhu Q, Shibata T, & Kai M (2017). Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker. Sci Rep 7: 40670.
Zhao LL, Wang YQ, Cao DY, Chen TT, Wang Q, Li YL, et al. (2015). Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: 2. Structure-Based Optimization. J Med Chem 58: 1281-1297.
Zozulya AL, & Wiendl H (2008). The role of regulatory T cells in multiple sclerosis. Nat Clin Pract Neurol 4: 384-398.